EBEamon F. X. Byrne

Eamon F. X. Byrne

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eamon F. X. Byrne has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discovery and Validation of Alternatives to VSV-G for Pseudotyping of Lentiviral Vectors for In Vivo Delivery of Anti-Tumor Transgenes

    by M.J. Spindler, A. Amezquita, E.F.X. Byrne, R. Edgar, S. Ravi, S. Sandhu, T. Weller, D.S. Johnson

    Though cell therapy for cancer is now widely used commercially and has been efficacious for tens of thousands of patients, conventional manufacturing methods are expensive and difficult to scale. An alternative approach is to deliver the relevant anti-tumor transgenes to T cells in vivo in the patient. Such “ in vivo cell therapy” methods promise to be more scalable, with reduced cost of goods, since the same drug product can be administered to any patient. Typically, conventional cell therapy introduces anti-tumor transgenes into T cells using a lentivector pseudotyped with VSV-G. However, VSV-G is not cell type specific because its molecular target is present on a diversity of human cells, which may result in less than optimal pharmacology in vivo . Nature’s existing viral diversity presents the opportunity to identify alternative pseudotypes that are more optimal for in vivo cell therapy. In this study, we first performed a large-scale bioinformatic sequence search for G-proteins similar to VSV-G. We identified 166 G-proteins in the sequence search and then tested 9 in vitro for efficiency, specificity, and sensitivity of transgene delivery to various human immune cell phenotypes. We used the results from this screen to select three G-protein candidates for a pilot GFP transgene delivery study in humanized mice, using anti-CD3 antibody fragments for T cell tropism. One candidate G-protein performed significantly better than VSV-G, so we moved that candidate into tumor control studies in a humanized mouse model. This candidate G-protein was able to deliver an anti-tumor transgene to T cells, which subsequently cleared 100% of tumor burden in 100% of mice. We conclude that systematic screens for optimal lentivector designs can be used to identify optimized candidates for in vivo cell therapy.

  • Open Access

    SURPAS Long Range Planning Report 2023

    by Eamon Byrne, Tim MG MacKenzie, Aranyak Goswami, Samyuktha Suresh, M. Usman Ahmad

    Since early 2020, the Stanford University Postdoc Association, known as SURPAS, has been building a community-oriented vision for the future of postdocs at Stanford. This effort sought to answer the question: “What do postdocs think about the postdoc role?” During this process, we analyzed historical postdoc advocacy, held twelve focus group discussions, and collected details of contemporary advocacy efforts into a single document. More than 70 individuals engaged with the Report in the drafting stage, providing hundreds of comments to reflect the vision of the whole postdoc community at Stanford. This Report details the difficulties faced by postdocs at Stanford and provides an extensive list of recommended action items for various stakeholders, including postdoc advocacy groups, university faculty, university administrators, and national funding bodies. This Report was officially endorsed by the SURPAS Council on Thursday, March 30, 2023.

  • Open Access

    Structural basis for ion selectivity in potassium-selective channelrhodopsins

    by Seiya Tajima, Yoon Seok Kim, Masahiro Fukuda, Eamon F.X. Byrne, Peter Y. Wang, Joseph M. Paggi, Koichiro E. Kishi, Charu Ramakrishnan, Syunki Takaramoto, Takashi Nagata, et al.

    SUMMARY: The KCR channelrhodopsins are recently-discovered light-gated ion channels with high K + selectivity, a property that has attracted broad attention among biologists– due to intense interest in creating novel inhibitory tools for optogenetics leveraging this K + selectivity, and due to the mystery of how this selectivity is achieved in the first place. Indeed, the molecular and structural mechanism for K + selectivity in KCRs has remained especially puzzling since these 7-transmembrane retinal-binding proteins completely lack structural similarity with known K + channels, which generally coordinate K + in a precisely symmetric conduction pathway formed by a tight interface among multiple small monomeric channel subunits (presumably not an accessible mechanism for the large KCR rhodopsin proteins). Here we present the cryo-electron microscopy structures of two KCRs from Hyphochytrium catenoides with distinct spectral properties for light absorption and channel actuation, Hc KCR1, and Hc KCR2, at resolutions of 2.6 and 2.5 Å, respectively. Structural comparison revealed first an unusually-shaped retinal binding pocket which induces rotation of the retinal in Hc KCR2, explaining the large spectral difference between Hc KCR1 and 2. Next, our combined structural, electrophysiological, computational, and spectroscopic analyses revealed a new solution to the challenging problem of K + -selective transport. KCRs indeed do not exhibit the canonical tetrameric K + selectivity filter that specifically coordinates dehydrated K + ; instead, single KCR monomers form a size exclusion filter using aromatic residues at the extracellular side of the pore which inhibits passage of bulky hydrated ions. This unique feature allows KCRs to function as K + channels under relevant physiological conditions, providing not only a novel mechanism for achieving high K + permeability ratios in biological ion channels, but also a framework for designing the next generation of inhibitory optogenetic tools. In Brief: The first structures of K + -selective channelrhodopsins ( Hc KCR1 and 2) are determined, revealing a K + selectivity mechanism distinctly different from canonical K + channels. Highlights: The cryo-EM structures of K + -selective channelrhodopsins, Hc KCR1 and 2, in nanodisc Conditions under which naturally-occurring microbial rhodopsins have a 6-s- cis retinal Identification of key residues for high K + permeability ratios The unique K + selectivity mechanism of KCRs


  • Open Access

    Patched 1 regulates Smoothened by controlling sterol binding to its extracellular cysteine-rich domain

    by Maia Kinnebrew, Rachel E. Woolley, T. Bertie Ansell, Eamon F. X. Byrne, Sara Frigui, Giovanni Luchetti, Ria Sircar, Sigrid Nachtergaele, Laurel Mydock-McGrane, Kathiresan Krishnan, et al.

    Smoothened (SMO) transduces the Hedgehog (Hh) signal across the plasma membrane in response to accessible cholesterol. Cholesterol binds SMO at two sites: one in the extracellular cysteine-rich domain (CRD) and a second in the transmembrane domain (TMD). How these two sterol-binding sites mediate SMO activation in response to the ligand Sonic Hedgehog (SHH) remains unknown. We find that mutations in the CRD (but not the TMD) reduce the fold increase in SMO activity triggered by SHH. SHH also promotes the photocrosslinking of a sterol analog to the CRD in intact cells. In contrast, sterol binding to the TMD site boosts SMO activity regardless of SHH exposure. Mutational and computational analyses show that these sites are in allosteric communication despite being 45 angstroms apart. Hence, sterols function as both SHH-regulated orthosteric ligands at the CRD and allosteric ligands at the TMD to regulate SMO activity and Hh signaling.


  • Open Access

    Structure, mechanism, and inhibition of Hedgehog acyltransferase

    by Claire E. Coupland, Sebastian A. Andrei, T. Bertie Ansell, Loic Carrique, Pramod Kumar, Lea Sefer, Rebekka A. Schwab, Eamon F.X. Byrne, Els Pardon, Jan Steyaert, et al.


  • Open Access

    Structural basis for channel conduction in the pump-like channelrhodopsin ChRmine

    by Koichiro E. Kishi, Yoon Seok Kim, Masahiro Fukuda, Tsukasa Kusakizako, Elina Thadhani, Eamon F.X. Byrne, Joseph M. Paggi, Charu Ramakrishnan, Toshiki E. Matsui, Keitaro Yamashita, et al.

    Summary: ChRmine 1 , a recently-discovered bacteriorhodopsin-like cation-conducting channelrhodopsin 1, 2 , exhibits puzzling properties (unusually-large photocurrents, exceptional red-shift in action spectrum, and extreme light-sensitivity) that have opened up new opportunities in optogenetics 1, 3–5 . ChRmine and its homologs function as light-gated ion channels, but by primary sequence more closely resemble ion pump rhodopsins; the molecular mechanisms for passive channel conduction in this family of proteins, as well as the unusual properties of ChRmine itself, have remained mysterious. Here we present the cryo-electron microscopy structure of ChRmine at 2.0 Å resolution. The structure reveals striking architectural features never seen before in channelrhodopsins including trimeric assembly, a short transmembrane-helix 3 unwound in the middle of the membrane, a prominently-twisting extracellular-loop 1, remarkably-large intracellular cavities and extracellular vestibule, and an unprecedented hydrophilic pore that extends through the center of the trimer, separate from the three individual monomer pores. Electrophysiological, spectroscopic, and computational analyses provide insight into conduction and gating of light-gated channels with these distinct design features, and point the way toward structure-guided creation of novel channelrhodopsins for optogenetic applications in biology.


  • Open Access

    Structure and Mechanism of Hedgehog Acyl Transferase

    by Claire E. Coupland, Sebastian A. Andrei, T. Bertie Ansell, Loic Carrique, Pramod Kumar, Lea Sefer, Rebekka A Schwab, Eamon F.X. Byrne, Els Pardon, Jan Steyaert, et al.

    SUMMARY: The iconic Sonic Hedgehog (SHH) morphogen pathway is a fundamental orchestrator of embryonic development and stem cell maintenance, and is implicated in cancers in various organs. A key step in signalling is transfer of a palmitate group to the N-terminal cysteine residue of SHH, catalysed by the multi-pass transmembrane enzyme Hedgehog acyltransferase (HHAT) resident in the endoplasmic reticulum (ER). Here, we present the high-resolution cryo-EM structure of HHAT bound to substrate analogue palmityl-coenzyme A and a SHH mimetic megabody. Surprisingly, we identified a heme group bound to an HHAT cysteine residue and show that this modification is essential for HHAT structure and function. A structure of HHAT bound to potent small molecule inhibitor IMP-1575 revealed conformational changes in the active site which occlude substrate binding. Our multidisciplinary analysis provides a detailed view of the novel mechanism by which HHAT adapts the membrane environment to transfer a long chain fatty acid across the ER membrane from cytosolic acyl-CoA to a luminal protein substrate. This structure of a member of the protein-substrate membrane-bound O-acyltransferase (MBOAT) superfamily provides a blueprint for other protein substrate MBOATs, such as WNT morphogen acyltransferase Porcupine and ghrelin O -acyltransferase GOAT, and a template for future drug discovery.


  • Open Access

    A serine in the first transmembrane domain of the human E3 ubiquitin ligase MARCH9 is critical for down-regulation of its protein substrates

    by Cyrus Tan, Eamon F.X. Byrne, Casey Ah-Cann, Melissa J. Call, Matthew E. Call


  • Cilia-Associated Oxysterols Activate Smoothened

    by David R. Raleigh, Navdar Sever, Pervinder K. Choksi, Monika Abedin Sigg, Kelly M. Hines, Bonne M. Thompson, Daniel Elnatan, Priyadarshini Jaishankar, Paola Bisignano, Francesc R. Garcia-Gonzalo, et al.